5-TERT-BUTYL-2-(3-FLUORO-PHENYL)-2H-PYRAZOL-3-YLAMINE

2-(2-METHOXYPHENOXY)ETHYL CHLORIDE

3-(2-Naphthyl)prop-2-ynoic acid

N-(3-CHLOROBENZYL)-N-CYCLOPROPYLAMINE

Carbamic acid, [2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxoethyl]-, 1,1-dimethylethyl ester

CarbaMic acid, [(2R)-2-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl)-2-hydroxyethyl]-, 1,1-diMethylethyl ester

2(1H)-QUINAZOLINONE, 1-(1-METHYLETHYL)-4-[4-(1-METHYLETHYL)PHENYL]-6-(2-PROPYN-1-YLOXY)-

(2S)-2-[[[[(1R,2R)-2-Aminocyclohexyl]amino]thioxomethyl]amino]-N-3,3-trimethyl-N-(phenylmethyl)butanamide, (S)-2-[[[[(1R,2R)-2-Aminocyclohexyl]amino]thioxomethyl]amino]-N-benzyl-N-3,3-trimethylbutanamide

Insulin-like Growth Factor-1 Receptor Inhibitor

IKK Inhibitor III, BMS-345541